Fundraising FoxNuvig Therapeutics
14 known investors
Find your way into Nuvig Therapeutics
Sign up to see every warm intro you have to Nuvig Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nuvig Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Nuvig Therapeutics is a biotech company developing immune-modulating therapies for autoimmune and chronic inflammatory diseases, using an endogenous regulatory mechanism intended to treat inflammation without compromising broader immune function. It targets patients with autoimmune conditions.
Investors · 14
How we know: Sanofi Ventures's portfolio page · funding news · nuvigtx.com · Not right? Tell us
How we know: nuvigtx.com · Not right? Tell us
How we know: nuvigtx.com · Not right? Tell us
How we know: nuvigtx.com · Not right? Tell us
How we know: nuvigtx.com · Not right? Tell us
How we know: funding news · nuvigtx.com · Not right? Tell us
How we know: funding news · nuvigtx.com · Not right? Tell us
Also in the syndicate · 3
Funding
SEC filings, press & company announcements$161M disclosed across 1 of 2 rounds · 2022–2024
- $161MSeries BDec 2024 · 2 sources
Blue Owl Healthcare Opportunities (lead), Norwest Venture Partners (lead), Sanofi Ventures (lead), abrdn Inc., Alexandria Venture Investments, B Capital, Bristol Myers Squibb, Digitalis Ventures, Global BioAccess Fund, Leaps by Bayer, LOTTE Holdings, Mission BioCapital, Novo Holdings A/S, Platanus
Source ↗ - Undisclosed amountSeries AMay 2022Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Nuvig Therapeutics do?
- Nuvig Therapeutics is a biotech company developing immune-modulating therapies for autoimmune and chronic inflammatory diseases, using an endogenous regulatory mechanism intended to treat inflammation without compromising broader immune function. It targets patients with autoimmune conditions.
- Who are Nuvig Therapeutics's investors?
- Nuvig Therapeutics's investors include Sanofi Ventures, abrdn plc, Alexandria, B Capital, Digitalis Ventures, Global BioAccess Fund, Leaps by Bayer, Mission Biocapital and 3 more.
- How much funding has Nuvig Therapeutics raised?
- Nuvig Therapeutics has disclosed $161M raised across 1 of its 2 known rounds.